Nipent

Nipent is a brand name of pentostatin, approved by the FDA in the following formulation(s):

NIPENT (pentostatin - injectable; injection)

• 
  Manufacturer: HOSPIRA INC
  
  Approval date: October 11, 1991
  
  Strength(s): 10MG/VIAL ^[RLD][AP]

Has a generic version of Nipent been approved?

Yes. The following products are equivalent to Nipent:

pentostatin injectable; injection

• 
  Manufacturer: BEDFORD LABS
  
  Approval date: August 7, 2007
  
  Strength(s): 10MG/VIAL ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Nipent. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Nipent.

See also...

• Nipent Consumer Information (Wolters Kluwer)
• Nipent Consumer Information (Cerner Multum)
• Nipent Advanced Consumer Information (Micromedex)
• Nipent AHFS DI Monographs (ASHP)
• Pentostatin Consumer Information (Wolters Kluwer)
• Pentostatin Consumer Information (Cerner Multum)
• Pentostatin Intravenous Advanced Consumer Information (Micromedex)
• Pentostatin AHFS DI Monographs (ASHP)